VIKING GLOBAL INVESTORS LP 13D/13G Filings for PMV Pharmaceuticals, Inc. (PMVP)

VIKING GLOBAL INVESTORS LP 13D and 13G filings for PMV Pharmaceuticals, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2022-02-14
5:01 pm
Sale
2021-12-3113GPMV PHARMACEUTICALS INC
PMVP
VIKING GLOBAL INVESTORS LP1,790,284
3.900%
-573,778decrease
(-24.27%)
Filing